Skip to main content
Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.

In accordance with Section 41c of the German Medicinal Products Act (AMG), the Commission deals with studies that meet special requirements. These include first-in-human studies, trials of medicinal products for advanced therapies and clinical trials with highly complex study designs.

ImmunoSensation2 member Prof. Schäfer is a specialist in internal medicine and rheumatology at the UKB and a member of the Transdisciplinary Research Area (TRA) “Life and Health” at the University of Bonn. His scientific focus is on image-based diagnostics of rheumatological diseases, the immunology of arthritis and myositis as well as innovative therapeutic concepts in rheumatology. “I am honored to be part of this important committee. The ethical evaluation of clinical trials is an essential pillar for the progress of medical science and the protection of patients,” says Prof. Schäfer.

With the appointment of Prof. Schäfer, the Specialized Ethics Committee has gained an outstanding scientific personality who will make a significant contribution to the responsible further development of medical research.

 

Contact

Prof. Dr. Valentin Sebastian Schäfer 

Medical Clinic III

University Hospital Bonn

Email: valentin.schaefer@ukbonn.de

 

 

 

Related news

PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry
20251103 PM Prof Wihelm

News categories: Honors & Funding

Prof. Christoph Wilhelm receives €1.25 million DFG funding for Reinhart-Koselleck project

The German Research Foundation (DFG) is funding a Reinhart-Koselleck project at the University Hospital Bonn (UKB) within the Cluster of Excellence ImmunoSensation² at the University of Bonn with €1.25 million. The research team led by Prof. Christoph Wilhelm, Chair of Immunopathology at the Institute of Clinical Chemistry and Clinical Pharmacology, aims to investigate how the body maintains the balance of the gut microbiome during periods of illness and food scarcity.
View entry

Back to the news overview